Dr. Reddy's launches generic Xeloda

Dr. Reddy’s is debuting capecitabine tablets.

The medication is the generic of Roche's Xeloda.

The Xeloda brand and generic had a market value of $90 million for the year ended October 2020, according to IQVIA.

Dr. Reddy’s capecitabine tablets are available in 150 mg and 500 mg dosage strengths.